Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
Powering precision proteomics to enable to the earliest detection of disease.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.
Exo Therapeutics is a small molecule drug discovery and development company.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.
Primmune Therapeutics is a Biotechnology company.
EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Link Cell Therapies is a biotechnology company that specializes in cancer cell therapy research and development services.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Enlaza Therapeutics is a biotechnology research company.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Abivax develops medicines that alter the body's natural immune system mechanisms.
Shenandoah Therapeutics is a biotechnology company.
Spyglass Pharma provides medicine for ophthalmic diseases.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 16 different industry categories.
Among tracked funding rounds, Abivax received $747.5M in a Post Ipo Equity round. Samsara BioCapital's total known invested capital is $12.8B.
Samsara BioCapital's average investment size is $105.2M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Alpine Immune Sciences, Arcellx, Alamar Biosciences, Centessa Pharmaceuticals, Cypherpunk Technologies (formerly Leap Therapeutics). These companies were founded in 2020 or later.